GIP/GLP

Description

Overview

GIP/GLP is a dual-agonist research peptide designed to activate both GIP and GLP-1 receptors. This combined signaling profile enables researchers to study incretin-based mechanisms involved in glucose regulation, metabolic balance, and complex peptide–receptor interactions. Its structural stability and optimized design make it a valuable reference for investigations into multi-receptor pathways and peptide engineering.

Product Details

• Purity: Research-grade, typically >99% (HPLC/MS verified)
• Status: Investigational peptide; not approved for therapeutic use
• Molecular Formula: C₂₂₅H₃₂₅N₅₅O₆₅
• Molecular Weight: ~4,800 g/mol
• CAS Number: 2023788-19-2
• Synonyms: Dual GIP/GLP-1 receptor agonist, LY3298176

Research Applications

• Dual Receptor Analysis: Supports the study of coordinated activation of GIP and GLP-1 receptors and their downstream metabolic effects.
• Incretin Biology Research: Enables examination of glucose utilization, insulin-related responses, and cellular signaling pathways.
• Peptide Optimization: Serves as a reference model for assessing peptide stability, receptor affinity, and multi-target designs.
• Metabolic Regulation Models: Assists in exploring energy expenditure, nutrient signaling, and metabolic control in research environments.

Usage & Safety

For laboratory research use only. Not approved for human or veterinary use and not for diagnostic or therapeutic applications. Handle under standard laboratory safety and storage guidelines.